Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Nystatin and Triamcinolone Acetonide Ointment USP12-11-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Nystatin and Triamcinolone Acetonide Ointment USPCadila Healthcare posts 17% dip in Q2 net to Rs 4.1 bn; revenue down 8.1%
Ebitda dipped 20% YoY to Rs 6.87 billionUnaudited Financial Results For The Quarter / Half Year Ended On September, 2018
Unaudited financial results for the quarter / half year ended on September, 2018 along with limited review report of the Statutory Auditors.Unaudited Financial Results For The Quarter / Half Year Ended On September 30, 2018
Please find attached the unaudited financial results of the Company for the quarter / half year ended on September 30, 2018 together with the Limited Review Report of the Statutory Auditors.Zydus Cadila launches generic erectile dysfunction drug in US market
Zydus Cadila has launched generic Vardenafil Hydrochloride tablets used for the treatment of erectile dysfunction in the American market.According toAnnouncement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Vardenafil Hydrochloride tablets and Ursodiol tabletsAnnouncement under Regulation 30 (LODR)-Acquisition
'Further to our letters dated August 13, 2018 and October 1, 2018, we hereby inform that the Company has subscribed 51% shares of Windlas Healthcare Private Limited (Windlas) as per the Share Purchase Agreement executed by the Company and Windlas. In view of the above, Windlas has become a subsidiary of the Company. This disclosure is made pursuant to Regulation 30(7) of the SEBI Listing Regulations, 2015....Zydus, Cadila to buy part of Heinz India biz for Rs 4,595 cr
Consumer brands Complan, Glucon-D, Nycil, Sampriti Ghee to change handsAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Company has planned investor interaction through a conference call on November 3, 2018 at 5:30 p.m., post announcement of unaudited financial results for the quarter / half year ended on September 30, 2018.Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed a Press Release with regard to proposed acquisition of 100% equity share capital of Heinz India Private Limited jointly with Zydus Wellness Limited.